gene therapy
November 7, 2016
July 27, 2016
July 26, 2016
November 12, 2013
July 24, 2013
PULLMAN, Wash. – The genes involved in the progression of prostate cancer from non-threatening to highly malignant are the focus of a new research project at Washington State University.
Grant D. Trobridge has received an award of $417,818 from the National Cancer Institute to identify which gene mutations cause the cancer to become threatening.
Prostate cancer is generally accepted as slow growing. It sometimes remains confined to the prostate gland and needs little or no treatment, while other times it spreads quickly.
“We know that several key genes have to be mutated before you get cancer,” Trobridge said. “Different tumors … » More …